Written Medicine Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

Written Medicine General Information


Provider of an online translation platform. The company engages in translating pharmacy labels into the patients' first language, avoiding any confusion and improving the chances of medicines being taken properly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Other Industries
Application Software
Primary Office
  • 41 Friars Place Lane
  • London W3 7AQ
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Written Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 27-Jul-2015 Completed Startup
To view Written Medicine’s complete valuation and funding history, request access »

Written Medicine Executive Team (3)

Name Title Board Seat Contact Info
Ghalib Khan Co-Founder & Director
Murtada Alsaif Ph.D Co-Founder
Tucker McGaw Co-Founder
To view Written Medicine’s complete executive team members history, request access »

Written Medicine Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Written Medicine Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bethnal Green Ventures Venture Capital Minority 000 0000 000000 0
DigitalHealth.London Accelerator Accelerator/Incubator 000 0000 000000 0
To view Written Medicine’s complete investors history, request access »